| # | Title | Journal | Year | Citations |
|---|
| 1 | International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) | Pharmacotherapy | 2019 | 545 |
| 2 | Validity of the General Practice Research Database | Pharmacotherapy | 2003 | 523 |
| 3 | Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions | Pharmacotherapy | 2008 | 487 |
| 4 | Illicit Use of Specific Prescription Stimulants Among College Students: Prevalence, Motives, and Routes of Administration | Pharmacotherapy | 2006 | 439 |
| 5 | Update: Clinically Significant Cytochrome P‐450 Drug Interactions | Pharmacotherapy | 1998 | 425 |
| 6 | Update: clinically significant cytochrome P-450 drug interactions | Pharmacotherapy | 1998 | 423 |
| 7 | Orlistat, a New Lipase Inhibitor for the Management of Obesity | Pharmacotherapy | 2000 | 373 |
| 8 | The Pharmacologic and Clinical Effects of Medical Cannabis | Pharmacotherapy | 2013 | 357 |
| 9 | Post Hoc Power Analysis: An Idea Whose Time Has Passed? | Pharmacotherapy | 2001 | 354 |
| 10 | The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal Dysfunction | Pharmacotherapy | 2000 | 347 |
| 11 | Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing | Pharmacotherapy | 2010 | 340 |
| 12 | The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance? | Pharmacotherapy | 2013 | 334 |
| 13 | Health Literacy: A Review | Pharmacotherapy | 2002 | 321 |
| 14 | Theophylline A “State of the Art” Review | Pharmacotherapy | 1983 | 320 |
| 15 | Statin-Associated Memory Loss: Analysis of 60 Case Reports and Review of the Literature | Pharmacotherapy | 2003 | 308 |
| 16 | Clinical Pharmacy Services, Pharmacy Staffing, and Hospital Mortality Rates | Pharmacotherapy | 2007 | 304 |
| 17 | Nosocomial Infections Due to Multidrug-ResistantPseudomonas aeruginosa: Epidemiology and Treatment Options | Pharmacotherapy | 2005 | 289 |
| 18 | Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use | Pharmacotherapy | 2008 | 272 |
| 19 | Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management | Pharmacotherapy | 2015 | 271 |
| 20 | American College of Clinical Pharmacy's Vision of the Future: Postgraduate Pharmacy Residency Training as a Prerequisite for Direct Patient Care Practice | Pharmacotherapy | 2006 | 261 |
| 21 | Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants | Pharmacotherapy | 2006 | 256 |
| 22 | The Definition of Clinical Pharmacy | Pharmacotherapy | 2008 | 255 |
| 23 | Therapeutic Monitoring of Vancomycin in Adults | Pharmacotherapy | 2009 | 253 |
| 24 | Cost and Quality Implications of Opioid‐Based Postsurgical Pain Control Using Administrative Claims Data from a Large Health System: Opioid‐Related Adverse Events and Their Impact on Clinical and Economic Outcomes | Pharmacotherapy | 2013 | 249 |
| 25 | Evidence of the Economic Benefit of Clinical Pharmacy Services: 1996–2000 | Pharmacotherapy | 2003 | 247 |
| 26 | Olanzapine-Associated Diabetes Mellitus | Pharmacotherapy | 2002 | 244 |
| 27 | Paradoxical Reactions to Benzodiazepines: Literature Review and Treatment Options | Pharmacotherapy | 2004 | 240 |
| 28 | Ketoprofen: A Review of Its Pharmacologic and Clinical Properties | Pharmacotherapy | 1986 | 239 |
| 29 | 2-Methoxyestradiol, a Promising Anticancer Agent | Pharmacotherapy | 2003 | 235 |
| 30 | Safety and Efficacy of Oxcarbazepine: Results of Randomized, Double-Blind Trials | Pharmacotherapy | 2000 | 234 |
| 31 | Oxcarbazepine in the Treatment of Epilepsy | Pharmacotherapy | 2001 | 234 |
| 32 | A Descriptive and Historical Review of Bibliometrics with Applications to Medical Sciences | Pharmacotherapy | 2015 | 233 |
| 33 | Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications | Pharmacotherapy | 2017 | 229 |
| 34 | Effects of Pharmacist Outpatient Interventions on Adults with Diabetes Mellitus: A Systematic Review | Pharmacotherapy | 2008 | 227 |
| 35 | Attention‐Deficit‐Hyperactivity Disorder: An Update | Pharmacotherapy | 2009 | 226 |
| 36 | Antimicrobial Dosing Considerations in Obese Adult Patients | Pharmacotherapy | 2007 | 222 |
| 37 | Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy | Pharmacotherapy | 2008 | 217 |
| 38 | A Review of Antibiotic Use in Pregnancy | Pharmacotherapy | 2015 | 217 |
| 39 | Application of Antimicrobial Pharmacodynamic Concepts into Clinical Practice: Focus on β-Lactam Antibiotics: Insights from the Society of Infectious Diseases Pharmacists | Pharmacotherapy | 2006 | 210 |
| 40 | Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort | Pharmacotherapy | 2017 | 207 |
| 41 | Ciprofloxacin: Chemistry, Mechanism of Action, Resistance, Antimicrobial Spectrum, Pharmacokinetics, Clinical Trials, and Adverse Reactions | Pharmacotherapy | 1988 | 199 |
| 42 | Remdesivir: Review of Pharmacology, Pre‐clinical Data, and Emerging Clinical Experience for COVID‐19 | Pharmacotherapy | 2020 | 197 |
| 43 | Dose-Related Effects of Methadone on QT Prolongation in a Series of Patients with Torsade de Pointes | Pharmacotherapy | 2003 | 195 |
| 44 | Clinical Pharmacy Services, Hospital Pharmacy Staffing, and Medication Errors in United States Hospitals | Pharmacotherapy | 2002 | 194 |
| 45 | The Echinocandins | Pharmacotherapy | 2007 | 193 |
| 46 | Comparison of Intramuscular Ketorolac Tromethamine and Morphine Sulfate for Analgesia of Pain After Major Surgery | Pharmacotherapy | 1986 | 189 |
| 47 | Pharmacokinetic and Pharmacodynamic Implications of P-glycoprotein Modulation | Pharmacotherapy | 2001 | 189 |
| 48 | Rates of Torsades de Pointes Associated with Ciprofloxacin, Ofloxacin, Levofloxacin, Gatifloxacin, and Moxifloxacin | Pharmacotherapy | 2001 | 188 |
| 49 | Scientific Collaboration Results in Higher Citation Rates of Published Articles | Pharmacotherapy | 2006 | 187 |
| 50 | Quazepam: Hypnotic Efficacy and Side Effects | Pharmacotherapy | 1990 | 185 |
